312 Participants Needed

ECHO Model for Advanced Cancer Care Quality

Sriram Yennu profile photo
Overseen BySriram Yennu
Age: Any Age
Sex: Any
Trial Phase: Phase 2
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to improve cancer care in underserved areas by understanding the experiences and satisfaction of patients with advanced cancer and their caregivers. It employs the Project ECHO model (Project Extension for Community Healthcare Outcomes), which enhances local healthcare through education and support. Participants include patients receiving advanced cancer treatment, their primary caregivers, and healthcare providers interested in improving cancer care. Participants will complete surveys and interviews about their care experiences, while healthcare providers will engage in educational sessions. This trial suits patients and caregivers involved in advanced cancer care and healthcare providers eager to improve care quality.

As a Phase 2 trial, the research focuses on measuring the treatment's effectiveness in an initial, smaller group of people, offering participants a chance to contribute to meaningful advancements in cancer care.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the research team or your doctor.

What prior data suggests that the ECHO model is safe for improving cancer care quality?

Research has shown that Project ECHO is popular in many healthcare settings. This program enables local healthcare providers to learn from specialists through online meetings and workshops. It's important to understand that Project ECHO is not a drug or medical treatment. Instead, it aims to improve how healthcare is delivered and taught.

No safety concerns have arisen because it involves sharing knowledge, not providing direct medical treatment. Participants in Project ECHO programs typically gain better access to healthcare information without negative effects. Thus, joining this trial appears safe and focuses on enhancing healthcare delivery rather than introducing a new medication or procedure.12345

Why are researchers excited about this trial?

Researchers are excited about the ECHO Model for Advanced Cancer Care Quality because it aims to improve cancer care by enhancing communication and education. Unlike many traditional treatments that focus solely on medical interventions, this approach uses ECHO clinics to connect healthcare providers through online sessions and workshops, expanding their knowledge and skills. This method also involves patients and caregivers in regular feedback loops, offering insights into their experiences and satisfaction, which can lead to more personalized and effective care. By focusing on education and engagement, the ECHO Model has the potential to provide comprehensive support and improve the overall quality of care for cancer patients.

What evidence suggests that the ECHO model is effective for improving cancer care quality?

Research has shown that Project ECHO, which participants in this trial will engage with, improves healthcare by connecting experts with local doctors, particularly in resource-limited areas. This approach enables rural healthcare providers to acquire specialist knowledge through online meetings, enhancing patient care. Studies have found that this method increases access to advanced care and aids in the earlier diagnosis of complex health issues. Project ECHO has succeeded in various locations, from Uruguay to Brazil, facilitating access to care for people in remote areas. The program leads to better medical practices and more satisfied patients and caregivers, suggesting it could significantly enhance cancer care in the trial regions.12678

Who Is on the Research Team?

Sriram Yennu | MD Anderson Cancer Center

Sriram Yennu

Principal Investigator

M.D. Anderson Cancer Center

Are You a Good Fit for This Trial?

This trial is for adult patients with advanced cancer and their caregivers in Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia. Participants must be able to read English and have a life expectancy of at least one year. Caregivers need to be the primary support person. Healthcare providers interested in Project ECHO can also join if they commit for two years.

Inclusion Criteria

My caregiver is at least 18 years old.
I am willing to stay in touch with the research team by phone or in person.
Patient has a prognosis of at least 1 year as ascertained by the treating physician
See 7 more

Exclusion Criteria

I am able to understand and sign the consent form.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

ECHO Clinics and Workshops

Participants participate in online ECHO clinics over 1 hour twice monthly for 12 months and in-country workshops twice per year.

12 months
24 online sessions, 2 in-country workshops

Patient and Caregiver Assessment

Patients and caregivers complete questionnaires and interviews about their experience and satisfaction with care.

24 months
3 in-person or phone questionnaires every 3 months for patients; up to 8 questionnaires for caregivers

Follow-up

Participants are monitored for changes in quality of life and symptom distress.

12 months

What Are the Treatments Tested in This Trial?

Interventions

  • Project ECHO
Trial Overview The trial evaluates Project ECHO's impact on palliative care quality through telementoring clinics, workshops, education programs for oncologists, medical chart reviews, and questionnaires assessing patient/caregiver satisfaction in underserved areas.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Group I: Arm III: Caregivers (questionnaire)Experimental Treatment1 Intervention
Group II: Arm II: Patients (questionnaire, medical chart review)Experimental Treatment2 Interventions
Group III: Arm I: ECHO Participants (ECHO clinics, workshop, education)Experimental Treatment3 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Published Research Related to This Trial

A new conceptual framework has been developed to create quality indicators for end-of-life care in advanced cancer patients, focusing on improving pain management, symptom relief, and coordination of care.
The framework outlines five essential steps for developing these indicators, ensuring they are evidence-based, feasible, and relevant to the needs of seriously ill patients and their families.
A framework for assessing quality indicators for cancer care at the end of life.Seow, H., Snyder, CF., Mularski, RA., et al.[2009]
Project ADAPT aims to improve care coordination for patients with metastatic breast cancer (MBC) by implementing a collaborative care model across multiple community hospitals, ensuring that patients receive optimal care regardless of their location.
The study is currently in the exploration phase, having recruited 21 participants to refine the collaborative care process, with plans to enroll more patients and oncologists to evaluate the model's impact on referral satisfaction and overall care experience.
Adapting and Developing an Academic and Community Practice Collaborative Care Model for Metastatic Breast Cancer Care (Project ADAPT): Protocol for an Implementation Science-Based Study.Housten, AJ., Okere, UC., Colditz, GA., et al.[2023]
Only 5.0% of patients with advanced solid tumors received outpatient specialty palliative care (OSPC) in 2016, highlighting a significant gap in access to these services.
Patients were 19 times more likely to use OSPC if their oncologist's practice was located in the same facility as the OSPC clinic, and those living closer (under 30 minutes) were also significantly more likely to access these services, indicating that clinic location and travel time are critical factors in OSPC utilization.
System-Level Factors Associated With Use of Outpatient Specialty Palliative Care Among Patients With Advanced Cancer.Yu, JA., Ray, KN., Park, SY., et al.[2023]

Citations

Project Extension for Community Healthcare OutcomesThe ECHO (Extension for Community Healthcare Outcomes) Project was designed to educate and train laboratory and healthcare professionals on ...
Project ECHO: Extension for Community Healthcare ...Project ECHO connects urban medical center disease experts with rural general practitioners and community health representatives over a telehealth network.
3.projectecho.unm.eduprojectecho.unm.edu/
Project ECHO: HomeThrough Project ECHO, health care providers from Uruguay to Brazil are improving access to early diagnosis and advanced care for complex cases. Read More · El ...
Project ECHO - Home PageProject ECHO® (Extension for Community Healthcare Outcomes) is a teleconsulting and telementoring partnership between MD Anderson specialists and providers ...
“Mind the Gap” - An overview of the role of the Extensions ...The aim of this review is to examine the impact that ECHO has on clinical practice and how such impacts are measured or evaluated.
Project ECHO | Agency for Healthcare Research and QualityA collaborative model of medical education and care management that helps clinicians provide expert-level care to patients wherever they live.
Project ECHO (Extension for Community Health Outcomes)At ECHO, our mission is to democratize medical knowledge and get best practice care to underserved people all over the world. Our goal is to touch the lives of ...
Project ECHO (Extension for Community Healthcare ...ECHO is a distance education model that connects specialists with numerous PCPs via simultaneous video link for the purpose of facilitating case-based learning.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security